Early detection of cancer using circulating tumor DNA: biological, physiological and analytical considerations

References

• Stewart B, Wild CP. World Cancer Report 2014. 2014. Available from: https://www.esmo.org/Oncology-News/World-Cancer-Report-2014.
   Google Scholar
• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.
   PubMed Web of Science ®Google Scholar
• Organização Mundial de Saúde OMS. Guide To Cancer Early Diagnosis. 2017. Available from: http://www1.inca.gov.br/rbc/n_63/v01/pdf/08-review-guide-to-cancer-early-diagnosis.pdf.
   Google Scholar
• Cho H, Mariotto AB, Schwartz LM, et al. When do changes in cancer survival mean progress? The insight from population incidence and mortality. J Natl Cancer Inst Monogr. 2014;2014(49):187–197.
   PubMedGoogle Scholar
• Galli C, Basso D, Plebani M. CA 19-9: handle with care. Clin Chem Lab Med. 2013;51(7):1369–1383.
   PubMed Web of Science ®Google Scholar
• Sikaris KA. CA125—A test with a change of heart. Heart Lung Circ. 2011;20(10):634–640.
   PubMed Web of Science ®Google Scholar
• Mazzucchelli R, Colanzi P, Pomante R, et al. Prostate tissue and serum markers. Adv Clin Path. 2000;4(3):111–120.
   PubMedGoogle Scholar
• Morell AR. CEA serum levels in non-neoplastic disease. Int J Biol Markers. 1992;7(3):160–166.
   PubMedGoogle Scholar
• Diehl F, Schmidt K, Durkee KH, et al. Analysis of mutations in DNA isolated from plasma and stool of colorectal cancer patients. Gastroenterology. 2008;135(2):489–498.
   PubMed Web of Science ®Google Scholar
• Phallen J, Sausen M, Adleff V, et al. Direct detection of early-stage cancers using circulating tumor DNA. Sci Transl Med. 2017;9(403):eaan2415. DOI:10.1126/scitranslmed.aan2415
   PubMed Web of Science ®Google Scholar
• Nelson HD, O'Meara ES, Kerlikowske K, et al. Factors associated with rates of false-positive and false-negative results from digital mammography screening: An analysis of registry data. Ann Intern Med. 2016;164(4):226–235.
   PubMed Web of Science ®Google Scholar
• Nelson HD, Pappas M, Cantor A, et al. Harms of breast cancer screening: Systematic review to update the 2009 U.S. Preventive Services Task Force Recommendation. Ann Intern Med. 2016;164(4):256–267.
   PubMed Web of Science ®Google Scholar
• Team NLSTR. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395–409.
   PubMed Web of Science ®Google Scholar
• Chou R, Croswell JM, Dana T, et al. Screening for prostate cancer: a review of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2011;155(11):762–771.
   PubMed Web of Science ®Google Scholar
• Mouliere F, Mair R, Chandrananda D, et al. Detection of cell-free DNA fragmentation and copy number alterations in cerebrospinal fluid from glioma patients. EMBO Mol Med. 2018;10(12):e9323-e9323.
   Web of Science ®Google Scholar
• Mouliere F, Robert B, Arnau Peyrotte E, et al. High fragmentation characterizes tumour-derived circulating DNA. PLoS One. 2011;6(9):e23418.
   PubMed Web of Science ®Google Scholar
• Cristiano S, Leal A, Phallen J, et al. Genome-wide cell-free DNA fragmentation in patients with cancer. Nature. 2019;570(7761):385–389.
   PubMed Web of Science ®Google Scholar
• Snyder MW, Kircher M, Hill AJ, et al. Cell-free DNA Comprises an in vivo nucleosome footprint that informs its tissues-of-origin. Cell. 2016;164(1–2):57–68.
   PubMed Web of Science ®Google Scholar
• Ulz P, Thallinger GG, Auer M, et al. Inferring expressed genes by whole-genome sequencing of plasma DNA. Nat Genet. 2016;48(10):1273–1278.
   PubMed Web of Science ®Google Scholar
• Ulz P, Perakis S, Zhou Q, et al. Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection. Nat Commun. 2019;10(1):4666.
   PubMedGoogle Scholar
• Bettegowda C, Sausen M, Leary RJ, et al. Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med. 2014;6(224):224ra24.
   PubMed Web of Science ®Google Scholar
• Diaz LA, Bardelli A. Liquid biopsies: Genotyping circulating tumor DNA. J Clin Oncol. 2014;32(6):579–586.
   PubMed Web of Science ®Google Scholar
• Shen SY, Singhania R, Fehringer G, et al. Sensitive tumour detection and classification using plasma cell-free DNA methylomes. Nature. 2018;563(7732):579–583.
   PubMed Web of Science ®Google Scholar
• Xu RH, Wei W, Krawczyk M, et al. Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma. Nature Mater. 2017;16(11):1155–1161.
   PubMed Web of Science ®Google Scholar
• Rahier JF, Druez A, Faugeras L, et al. Circulating nucleosomes as new blood-based biomarkers for detection of colorectal cancer. Clin Epigenet. 2017;9(1):53. eCollection 2017.
   PubMedGoogle Scholar
• Gezer U, Holdenrieder S. Post-translational histone modifications in circulating nucleosomes as new biomarkers in colorectal cancer. In Vivo. 2014;28(3):287–292.
   PubMed Web of Science ®Google Scholar
• Tanos R, Thierry AR. Clinical relevance of liquid biopsy for cancer screening. Transl Cancer Res. 2018;7(S2):S105–S129.
   Google Scholar
• Fleischhacker M, Schmidt B. Circulating nucleic acids (CNAs) and cancer–a survey. Biochim Biophys Acta. 2007;1775(1):181–232.
   PubMed Web of Science ®Google Scholar
• Abbosh C, Birkbak NJ, Wilson GA, et al. Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution. Nature. 2017;545(7655):446–451.
   PubMed Web of Science ®Google Scholar
• Parkinson CA, Gale D, Piskorz AM, et al. Exploratory analysis of TP53 mutations in circulating tumour DNA as biomarkers of treatment response for patients with relapsed high-grade serous ovarian carcinoma: a retrospective study. PLoS Med. 2016;13(12):e1002198.
   PubMed Web of Science ®Google Scholar
• Gorges TM, Schiller J, Schmitz A, et al. Cancer therapy monitoring in xenografts by quantitative analysis of circulating tumor DNA. Biomarkers. 2012;17(6):498–506.
   PubMed Web of Science ®Google Scholar
• Thierry AR, Mouliere F, Gongora C, et al. Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts. Nucleic Acids Res. 2010;38(18):6159–6175.
   PubMed Web of Science ®Google Scholar
• Kamat AA, Bischoff FZ, Dang D, et al. Circulating cell-free DNA: a novel biomarker for response to therapy in ovarian carcinoma. Cancer Biol Ther. 2006;5(10):1369–1374.
   PubMed Web of Science ®Google Scholar
• Newman AM, Bratman SV, To J, et al. An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage. Nat Med. 2014;20(5):548–554.
   PubMed Web of Science ®Google Scholar
• Forshew T, Murtaza M, Parkinson C, et al. Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA. Sci Transl Med. 2012;4(136):136ra68.
   PubMed Web of Science ®Google Scholar
• Tian G, Li X, Xie Y, et al. The early diagnosis in lung cancer by the detection of circulating tumor DNA. bioRxiv. 2017. DOI:10.1101/189340
   Google Scholar
• Cohen JD, Li L, Wang Y, et al. Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science. 2018;359(6378):926–930.
   PubMed Web of Science ®Google Scholar
• Cohen PA, Flowers N, Tong S, et al. Abnormal plasma DNA profiles in early ovarian cancer using a non-invasive prenatal testing platform: implications for cancer screening. BMC Med. 2016;14(1):126.
   PubMedGoogle Scholar
• Kinde I, Bettegowda C, Wang Y, et al. Evaluation of DNA from the Papanicolaou test to detect ovarian and endometrial cancers. Sci Transl Med. 2013;5(167):167ra4.
   PubMed Web of Science ®Google Scholar
• Chan KCA, Woo JKS, King A, et al. Analysis of Plasma Epstein-Barr virus DNA to screen for nasopharyngeal cancer. N Engl J Med. 2017;377(6):513–522.
   PubMed Web of Science ®Google Scholar
• Sun K, Jiang P, Chan KC, et al. Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments. Proc Natl Acad Sci USA. 2015;112(40):E5503–12.
   PubMed Web of Science ®Google Scholar
• Bianchi DW, Chudova D, Sehnert AJ, et al. Noninvasive prenatal testing and incidental detection of occult maternal malignancies. JAMA. 2015;314(2):162–169.
   PubMed Web of Science ®Google Scholar
• Amant F, Verheecke M, Wlodarska I, et al. Presymptomatic identification of cancers in pregnant women during noninvasive prenatal testing. JAMA Oncol. 2015;1(6):814–819.
   PubMed Web of Science ®Google Scholar
• Gormally E, Vineis P, Matullo G, et al. TP53 and KRAS2 mutations in plasma DNA of healthy subjects and subsequent cancer occurrence: a prospective study. Cancer Res. 2006;66(13):6871–6876.
   PubMed Web of Science ®Google Scholar
• Mao L, Hruban RH, Boyle JO, et al. Detection of oncogene mutations in sputum precedes diagnosis of lung cancer. Cancer Res. 1994;54(7):1634–1637.
   PubMed Web of Science ®Google Scholar
• Thierry AR, El Messaoudi S, Gahan PB, et al. Origins, structures, and functions of circulating DNA in oncology. Cancer Metastasis Rev. 2016;35(3):347–376.
   PubMed Web of Science ®Google Scholar
• Lehmann-Werman R, Neiman D, Zemmour H, et al. Identification of tissue-specific cell death using methylation patterns of circulating DNA. Proc Natl Acad Sci USA. 2016;113(13):E1826–34.
   PubMed Web of Science ®Google Scholar
• Deichmann R, Radsak M, Tug S, et al. Exercise-induced increases in cell free DNA in human plasma originate predominantly from cells of the haematopoietic lineage. Exerc Immunol Rev. 2015;21(27):164–173.
   PubMedGoogle Scholar
• Rogers JC, Boldt D, Kornfeld S, et al. Excretion of deoxyribonucleic acid by lymphocytes stimulated with phytohemagglutinin or antigen. Proc Natl Acad Sci U S A. 1972;69(7):1685–1689.
   PubMed Web of Science ®Google Scholar
• Wu DC, Lambowitz AM. Facile single-stranded DNA sequencing of human plasma DNA via thermostable group II intron reverse transcriptase template switching. Sci Rep. 2017;7(1):8421.
   PubMedGoogle Scholar
• Wong FC, Sun K, Jiang P, et al. Cell-free DNA in maternal plasma and serum: A comparison of quantity, quality and tissue origin using genomic and epigenomic approaches. Clin Biochem. 2016;49(18):1379–1386.
   PubMed Web of Science ®Google Scholar
• Roadmap Epigenomics C, Kundaje A, Meuleman W, et al. Integrative analysis of 111 reference human epigenomes. Nature. 2015;518(7539):317–330.
   PubMed Web of Science ®Google Scholar
• Fernandez AF, Assenov Y, Martin-Subero JI, et al. A DNA methylation fingerprint of 1628 human samples. Genome Res. 2012;22(2):407–419.
   PubMed Web of Science ®Google Scholar
• Zemmour H, Planer D, Magenheim J, et al. Non-invasive detection of human cardiomyocyte death using methylation patterns of circulating DNA. Nat Commun. 2018;9(1):1443.
   PubMedGoogle Scholar
• Tang W, Wan S, Yang Z, et al. Tumor origin detection with tissue-specific miRNA and DNA methylation markers. Bioinformatics. 2018;34(3):398–406.
   PubMed Web of Science ®Google Scholar
• Kang S, Li Q, Chen Q, et al. CancerLocator: non-invasive cancer diagnosis and tissue-of-origin prediction using methylation profiles of cell-free DNA. Genome Biol. 2017;18(1):53.
   PubMedGoogle Scholar
• Guo S, Diep D, Plongthongkum N, et al. Identification of methylation haplotype blocks aids in deconvolution of heterogeneous tissue samples and tumor tissue-of-origin mapping from plasma DNA. Nat Genet. 2017;49(4):635–642.
   PubMed Web of Science ®Google Scholar
• Moran S, Martinez-Cardus A, Sayols S, et al. Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis. Lancet Oncol. 2016;17(10):1386–1395.
   PubMed Web of Science ®Google Scholar
• Srivastava A, Karpievitch YV, Eichten SR, et al. HOME: a histogram based machine learning approach for effective identification of differentially methylated regions. BMC Bioinformatics. 2019;20(1):253.
   PubMedGoogle Scholar
• Plagnol V, Woodhouse S, Howarth K, et al. Analytical validation of a next generation sequencing liquid biopsy assay for high sensitivity broad molecular profiling. PLoS One. 2018;13(3):e0193802. eCollection 2018.
   PubMed Web of Science ®Google Scholar
• Yang S, Che SP, Kurywchak P, et al. Detection of mutant KRAS and TP53 DNA in circulating exosomes from healthy individuals and patients with pancreatic cancer. Cancer Biol Ther. 2017;18(3):158–165.
   PubMed Web of Science ®Google Scholar
• Anglesio MS, Papadopoulos N, Ayhan A, et al. Cancer-associated mutations in endometriosis without cancer. N Engl J Med. 2017;376(19):1835–1848.
   PubMed Web of Science ®Google Scholar
• Schwaederle M, Husain H, Fanta PT, et al. Detection rate of actionable mutations in diverse cancers using a biopsy-free (blood) circulating tumor cell DNA assay. Oncotarget. 2016;7(9):9707–9717.
   PubMed Web of Science ®Google Scholar
• Newman AM, Lovejoy AF, Klass DM, et al. Integrated digital error suppression for improved detection of circulating tumor DNA. Nat Biotechnol. 2016;34(5):547–555.
   PubMed Web of Science ®Google Scholar
• Fernandez-Cuesta L, Perdomo S, Avogbe PH, et al. Identification of circulating tumor DNA for the early detection of small-cell lung cancer. EBioMedicine. 2016;10:117–123.
   PubMed Web of Science ®Google Scholar
• Alexandrov LB, Jones PH, Wedge DC, et al. Clock-like mutational processes in human somatic cells. Nat Genet. 2015;47(12):1402–1407.
   PubMed Web of Science ®Google Scholar
• Genovese G, Kahler AK, Handsaker RE, et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J Med. 2014;371(26):2477–2487.
   PubMed Web of Science ®Google Scholar
• Hu Y, Ulrich BC, Supplee J, et al. False-positive plasma genotyping due to clonal hematopoiesis. Clin Cancer Res. 2018;24(18):4437–4443.
   PubMed Web of Science ®Google Scholar
• Aucamp J, Bronkhorst AJ, Badenhorst CPS, et al. The diverse origins of circulating cell-free DNA in the human body: a critical re-evaluation of the literature. Biol Rev. 2018;93(3):1649–1683.
   PubMed Web of Science ®Google Scholar
• Holdenrieder S, Stieber P. Apoptotic markers in cancer. Clin Biochem. 2004;37(7):605–617.
   PubMed Web of Science ®Google Scholar
• Nagata S, Nagase H, Kawane K, et al. Degradation of chromosomal DNA during apoptosis. Cell Death Differ. 2003;10(1):108–116.
   PubMed Web of Science ®Google Scholar
• Aucamp J, Calitz C, Bronkhorst AJ, et al. Cell-free DNA in a three-dimensional spheroid cell culture model: a preliminary study. Int J Biochem Cell Biol. 2017;89(June):182–192.
   PubMedGoogle Scholar
• Formichi P, Radi E, Battisti C, et al. Human fibroblasts undergo oxidative stress‐induced apoptosis without internucleosomal DNA fragmentation. J Cell Physiol. 2006;208(2):289–297.
   PubMed Web of Science ®Google Scholar
• Delgado PO, Alves BC, Gehrke Fde S, et al. Characterization of cell-free circulating DNA in plasma in patients with prostate cancer. Tumor Biol. 2013;34(2):983–986.
   PubMed Web of Science ®Google Scholar
• Umetani N, Hiramatsu S, Hoon DS. Higher amount of free circulating DNA in serum than in plasma is not mainly caused by contaminated extraneous DNA during separation. Ann N Y Acad Sci. 2006;1075(1):299–307.
   PubMedGoogle Scholar
• Jiang WW, Zahurak M, Goldenberg D, et al. Increased plasma DNA integrity index in head and neck cancer patients. Int J Cancer. 2006;119(11):2673–2676.
   PubMed Web of Science ®Google Scholar
• Wang BG, Huang HY, Chen YC, et al. Increased plasma DNA integrity in cancer patients. Cancer Res. 2003;63(14):3966–3968.
   PubMed Web of Science ®Google Scholar
• Leon SA, Green A, Yaros MJ, et al. Radioimmunoassay for nanogram quantities of DNA. J Immunol Methods. 1975;9(2):157–164.
   PubMed Web of Science ®Google Scholar
• Breitbach S, Sterzing B, Magallanes C, et al. Direct measurement of cell-free DNA from serially collected capillary plasma during incremental exercise. J Appl Physiol (1985). 2014;117(2):119–130.
   PubMed Web of Science ®Google Scholar
• Beiter T, Fragasso A, Hudemann J, et al. Neutrophils release extracellular DNA traps in response to exercise. J Appl Physiol (1985). 2014;117(3):325–333.
   PubMed Web of Science ®Google Scholar
• Mair R, Mouliere F, Smith CG, et al. Measurement of plasma cell-free mitochondrial tumor DNA improves detection of glioblastoma in patient-derived orthotopic xenograft models. Cancer Res. 2019;79(1):220–230.
   PubMed Web of Science ®Google Scholar
• Boyapati RK, Tamborska A, Dorward DA, et al. Advances in the understanding of mitochondrial DNA as a pathogenic factor in inflammatory diseases. F1000Res. 2017;6:169. eCollection 2017.
   PubMedGoogle Scholar
• Zhang R, Nakahira K, Guo X, et al. Very short mitochondrial DNA fragments and heteroplasmy in human plasma. Sci Rep. 2016;6(1):36097.
   PubMedGoogle Scholar
• Zhong S, Ng MC, Lo YM, et al. Presence of mitochondrial tRNA(Leu(UUR)) A to G 3243 mutation in DNA extracted from serum and plasma of patients with type 2 diabetes mellitus. J Clin Pathol. 2000;53(6):466–469.
   PubMed Web of Science ®Google Scholar
• Burnham P, Kim MS, Agbor-Enoh S, et al. Single-stranded DNA library preparation uncovers the origin and diversity of ultrashort cell-free DNA in plasma. Sci Rep. 2016;6(1):27859.
   PubMedGoogle Scholar
• Jiang P, Chan CW, Chan KC, et al. Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients. Proc Natl Acad Sci USA. 2015;112(11):E1317–25.
   PubMed Web of Science ®Google Scholar
• Chandrananda D, Thorne NP, Bahlo M. High-resolution characterization of sequence signatures due to non-random cleavage of cell-free DNA. BMC Med Genomics. 2015;8(1):29.
   PubMedGoogle Scholar
• Ellinger J, Albers P, Muller SC, et al. Circulating mitochondrial DNA in the serum of patients with testicular germ cell cancer as a novel noninvasive diagnostic biomarker. BJU Int. 2009;104(1):48–52.
   PubMed Web of Science ®Google Scholar
• Panagopoulou M, Karaglani M, Balgkouranidou I, et al. Circulating cell-free DNA release in vitro: kinetics, size profiling, and cancer-related gene methylation. J Cell Physiol. 2019;234(8):14079–14089.
   PubMed Web of Science ®Google Scholar
• Wang W, Kong P, Ma G, et al. Characterization of the release and biological significance of cell-free DNA from breast cancer cell lines. Oncotarget. 2017;8(26):43180–43191.
   PubMedGoogle Scholar
• Aucamp J, Bronkhorst AJ, Peters DL, et al. Kinetic analysis, size profiling, and bioenergetic association of DNA released by selected cell lines in vitro. Cell Mol Life Sci. 2017;74(14):2689–2707.
   PubMed Web of Science ®Google Scholar
• Bronkhorst AJ, Wentzel JF, Aucamp J, et al. Characterization of the cell-free DNA released by cultured cancer cells. Biochim Biophys Acta. 2016;1863(1):157–165.
   PubMed Web of Science ®Google Scholar
• Gahan PB, Stroun M. The virtosome-a novel cytosolic informative entity and intercellular messenger. Cell Biochem Funct. 2010;28(7):529–538.
   PubMed Web of Science ®Google Scholar
• Stroun M, Lyautey J, Lederrey C, et al. About the possible origin and mechanism of circulating DNA Apoptosis and active DNA release. Clin Chim Acta. 2001;313:139–142.
   Google Scholar
• Stroun M, Anker P, Beljanski M, et al. Presence of RNA in the nucleoprotein complex spontaneously released by human lymphocytes and frog auricles in culture. Cancer Res. 1978;38(10):3546–3554.
   PubMed Web of Science ®Google Scholar
• Anker P, Stroun M, Maurice PA. Spontaneous release of DNA by human blood lymphocytes as shown in an in vitro system. Cancer Res. 1975;35(9):2375–2382.
   PubMed Web of Science ®Google Scholar
• Stroun M, Anker P. Nucleic acids spontaneously released by living frog auricles. Biochem J. 1972;128(3):100P–101P.
   PubMed Web of Science ®Google Scholar
• Borenstein S, Ephrati-Elizur E. Spontaneous release of DNA in sequential genetic order by Bacillus subtilis. J Mol Biol. 1969;45(1):137–152.
   PubMed Web of Science ®Google Scholar
• Bronkhorst AJ, Wentzel JF, Ungerer V, et al. Sequence analysis of cell-free DNA derived from cultured human bone osteosarcoma (143B) cells. Tumour Biol. 2018;40(9):101042831880119.
   Google Scholar
• Zhu J, Zhang F, Du M, et al. Molecular characterization of cell-free eccDNAs in human plasma. Sci Rep. 2017;7(1):10968.
   PubMedGoogle Scholar
• Kumar P, Dillon LW, Shibata Y, et al. Normal and cancerous tissues release extrachromosomal circular DNA (eccDNA) into the circulation. Mol Cancer Res. 2017;15(9):1197–1205.
   PubMed Web of Science ®Google Scholar
• Fenech M, Kirsch-Volders M, Natarajan AT, et al. Molecular mechanisms of micronucleus, nucleoplasmic bridge and nuclear bud formation in mammalian and human cells. Mutagenesis. 2011;26(1):125–132.
   PubMed Web of Science ®Google Scholar
• McClintock B. The fusion of broken ends of chromosomes following nuclear fusion. Proc Nat Acad Sci USA. 1942;28(11):458–463.
   PubMedGoogle Scholar
• Fernando MR, Jiang C, Krzyzanowski GD, et al. New evidence that a large proportion of human blood plasma cell-free DNA is localized in exosomes. PLoS One. 2017;12(8):e0183915. eCollection 2017.
   PubMed Web of Science ®Google Scholar
• Thakur BK, Zhang H, Becker A, et al. Double-stranded DNA in exosomes: a novel biomarker in cancer detection. Cell Res. 2014;24(6):766–769.
   PubMed Web of Science ®Google Scholar
• Ronquist G. Prostasomes are mediators of intercellular communication: From basic research to clinical implications. J Intern Med. 2012;271(4):400–413.
   PubMed Web of Science ®Google Scholar
• Sanchez C, Snyder MW, Tanos R, et al. New insights into structural features and optimal detection of circulating tumor DNA determined by single-strand DNA analysis. NPJ Genom Med. 2018;3(1):31.
   PubMedGoogle Scholar
• Underhill HR, Kitzman JO, Hellwig S, et al. Fragment length of circulating tumor DNA. PLoS Genet. 2016;12(7):e1006162.
   PubMed Web of Science ®Google Scholar
• Mouliere F, Chandrananda D, Piskorz AM, et al. Enhanced detection of circulating tumor DNA by fragment size analysis. Sci Transl Med. 2018;10(466):eaat4921–eaat4921.
   PubMed Web of Science ®Google Scholar
• Wan JCM, Massie C, Garcia-Corbacho J, et al. Liquid biopsies come of age: towards implementation of circulating tumour DNA. Nat Rev Cancer. 2017;17(4):223–238.
   PubMed Web of Science ®Google Scholar
• Serpas L, Chan RWY, Jiang P, et al. Dnase1l3 deletion causes aberrations in length and end-motif frequencies in plasma DNA. Proc Natl Acad Sci USA. 2019;116(2):641–649.
   PubMed Web of Science ®Google Scholar
• Van Der Vaart M, Pretorius PJ. Circulating DNA: Its origin and fluctuation. Ann N Y Acad Sci. 2008;1137(1):18–26.
   PubMedGoogle Scholar
• Jain A, Krishnamurthy PK, Landais P, et al. EKF for Joint mitigation of phase noise, frequency offset and nonlinearity in 400 Gb/s PM-16-QAM and 200 Gb/s PM-QPSK systems. IEEE Photonics J. 2017;9(1):1–10.
   Web of Science ®Google Scholar
• Bronkhorst AJ, Ungerer V, Holdenrieder S. The emerging role of cell-free DNA as a molecular marker for cancer management. Biomol Detect Quantif. 2019;17(March):100087. eCollection 2019 Mar.
   PubMedGoogle Scholar
• Yao W, Mei C, Nan X, et al. Evaluation and comparison of in vitro degradation kinetics of DNA in serum, urine and saliva: A qualitative study. Gene. 2016;590(1):142–148.
   PubMed Web of Science ®Google Scholar
• Diehl F, Schmidt K, Choti MA, et al. Circulating mutant DNA to assess tumor dynamics. Nat Med. 2008;14(9):985–990.
   PubMed Web of Science ®Google Scholar
• To EW, Chan KC, Leung SF, et al. Rapid clearance of plasma Epstein-Barr virus DNA after surgical treatment of nasopharyngeal carcinoma. Clin Cancer Res. 2003;9(9):3254–3259.
   PubMed Web of Science ®Google Scholar
• Alekseeva LA, Mironova NL, Brenner EV, et al. Alteration of the exDNA profile in blood serum of LLC-bearing mice under the decrease of tumour invasion potential by bovine pancreatic DNase I treatment. PLoS One. 2017;12(2):e0171988. eCollection 2017.
   PubMed Web of Science ®Google Scholar
• Tamkovich SN, Cherepanova AV, Kolesnikova EV, et al. Circulating DNA and DNase activity in human blood. Ann N Y Acad Sci. 2006;1075(1):191–196.
   PubMedGoogle Scholar
• Reckamp KL, Melnikova VO, Karlovich C, et al. A highly sensitive and quantitative test platform for detection of NSCLC EGFR mutations in urine and plasma. J Thorac Oncol. 2016;11(10):1690–1700.
   PubMed Web of Science ®Google Scholar
• Miranda KC, Bond DT, McKee M, et al. Nucleic acids within urinary exosomes/microvesicles are potential biomarkers for renal disease. Kidney Int. 2010;78(2):191–199.
   PubMed Web of Science ®Google Scholar
• Botezatu I, Serdyuk O, Potapova G, et al. Genetic analysis of DNA excreted in urine: a new approach for detecting specific genomic DNA sequences from cells dying in an organism. Clin Chem. 2000;46(8 Pt 1):1078–1084.
   PubMed Web of Science ®Google Scholar
• Diehl F, Li M, Dressman D, et al. Detection and quantification of mutations in the plasma of patients with colorectal tumors. Proc Natl Acad Sci U S A. 2005;102(45):16368–16373.
   PubMed Web of Science ®Google Scholar
• Chused TM, Steinberg AD, Talal N. The clearance and localization of nucleic acids by New Zealand and normal mice. Clin Exp Immunol. 1972;12(4):465–476.
   PubMed Web of Science ®Google Scholar
• Tamkovich S, Laktionov P. Cell-surface-bound circulating DNA in the blood. Biol Clin Appl IUBMB Life. 2019;71(9):1201–1210.
   PubMed Web of Science ®Google Scholar
• Meddeb R, Pisareva E, Thierry AR. Guidelines for the preanalytical conditions for analyzing circulating cell-free DNA. Clin Chem. 2019;65(5):623–633.
   PubMed Web of Science ®Google Scholar
• Tsui DW, Barnett E, Scher HI. Toward standardization of preanalytical procedures for cell-free DNA profiling. Clin Chem. 2019. DOI:10.1373/clinchem.2019.310854
   PubMed Web of Science ®Google Scholar
• Bronkhorst AJ, Aucamp J, Pretorius PJ. Cell-free DNA: Preanalytical variables. Clin Chim Acta. 2015;450:243–253.
   PubMed Web of Science ®Google Scholar
• El Messaoudi S, Rolet F, Mouliere F, et al. Circulating cell free DNA: preanalytical considerations. Clin Chim Acta. 2013;424:222–230.
   PubMed Web of Science ®Google Scholar
• Heitzer E, Haque IS, Roberts CES, et al. Current and future perspectives of liquid biopsies in genomics-driven oncology. Nat Rev Genet. 2019;20(2):71–88.
   PubMed Web of Science ®Google Scholar
• Hellwig S, Nix DA, Gligorich KM, et al. Automated size selection for short cell-free DNA fragments enriches for circulating tumor DNA and improves error correction during next generation sequencing. PLoS One. 2018;13(7):e0197333.
   PubMed Web of Science ®Google Scholar
• Markus H, Contente-Cuomo T, Farooq M, et al. Evaluation of pre-analytical factors affecting plasma DNA analysis. Sci Rep. 2018;8(1):7375.
   PubMedGoogle Scholar
• Kloten V, Ruchel N, Bruchle NO, et al. Liquid biopsy in colon cancer: comparison of different circulating DNA extraction systems following absolute quantification of KRAS mutations using Intplex allele-specific PCR. Oncotarget. 2017;8(49):86253–86263.
   PubMedGoogle Scholar
• Lampignano R, Neumann MHD, Weber S, et al. Multicenter evaluation of circulating cell-free DNA extraction and downstream analyses for the development of standardized (pre)analytical work flows. Clin Chem. 2019;000:1–12.
   Google Scholar
• Schmidt B, Fleischhacker M. Is liquid biopsy ready for the litmus test and what has been achieved so far to deal with pre-analytical issues? Transl Cancer Res. 2018;7(S2):S130–S139.
   Google Scholar
• Haselmann V, Ahmad-Nejad P, Geilenkeuser WJ, et al. Results of the first external quality assessment scheme (EQA) for isolation and analysis of circulating tumour DNA (ctDNA). Clin Chem Lab Med. 2018;56(2):220–228.
   PubMed Web of Science ®Google Scholar
• Malentacchi F, Pazzagli M, Simi L, et al. SPIDIA-DNA: an external quality assessment for the pre-analytical phase of blood samples used for DNA-based analyses. Clin Chim Acta. 2013;424:274–286.
   PubMed Web of Science ®Google Scholar
• Malentacchi F, Pizzamiglio S, Verderio P, et al. Influence of storage conditions and extraction methods on the quantity and quality of circulating cell-free DNA (ccfDNA): the SPIDIA-DNAplas external quality assessment experience. Clin Chem Lab Med. 2015;53(12):1935–1942.
   PubMed Web of Science ®Google Scholar
• Fiala C, Diamandis EP. Utility of circulating tumor DNA in cancer diagnostics with emphasis on early detection. BMC Med. 2018;16(1):166.
   PubMedGoogle Scholar
• Aravanis AM, Lee M, Klausner RD. Next-generation sequencing of circulating tumor DNA for early cancer detection. Cell. 2017;168(4):571–574.
   PubMed Web of Science ®Google Scholar
• Manokhina I, Singh TK, Penaherrera MS, et al. Quantification of cell-free DNA in normal and complicated pregnancies: overcoming biological and technical issues. PLoS One. 2014;9(7):e101500.
   PubMed Web of Science ®Google Scholar
• Cohen JD, Javed AA, Thoburn C, et al. Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers. Proc Natl Acad Sci USA. 2017;114(38):10202–10207.
   PubMed Web of Science ®Google Scholar
• Hulbert A, Jusue-Torres I, Stark A, et al. Early detection of lung cancer using DNA promoter hypermethylation in plasma and sputum. Clin Cancer Res. 2017;23(8):1998–2005.
   PubMed Web of Science ®Google Scholar
• Fiala C, Diamandis EP. Can Grail find the trail to early cancer detection?. Clin Chem Lab Med. 2019;57(4):403–406.
   PubMed Web of Science ®Google Scholar
• Zhao H, Chen KZ, Hui BG, et al. Role of circulating tumor DNA in the management of early-stage lung cancer. Thorac Cancer. 2018;9(5):509–515.
   PubMed Web of Science ®Google Scholar
• Rohanizadegan M. Analysis of circulating tumor DNA in breast cancer as a diagnostic and prognostic biomarker. Cancer Genet. 2018;228-229:159–168.
   PubMed Web of Science ®Google Scholar
• Sina AA, Carrascosa LG, Liang Z, et al. Epigenetically reprogrammed methylation landscape drives the DNA self-assembly and serves as a universal cancer biomarker. Nat Commun. 2018;9(1):4915.
   PubMedGoogle Scholar
• Frenel JS, Carreira S, Goodall J, et al. Serial next-generation sequencing of circulating cell-free DNA evaluating tumor clone response to molecularly targeted drug administration. Clin Cancer Res. 2015;21(20):4586–4596.
   PubMed Web of Science ®Google Scholar
• Dawson SJ, Tsui DW, Murtaza M, et al. Analysis of circulating tumor DNA to monitor metastatic breast cancer. N Engl J Med. 2013;368(13):1199–1209.
   PubMed Web of Science ®Google Scholar
• Kinde I, Wu J, Papadopoulos N, et al. Detection and quantification of rare mutations with massively parallel sequencing. Proc Natl Acad Sci USA. 2011;108(23):9530–9535.
   PubMed Web of Science ®Google Scholar
• van der Pol Y, Mouliere F. Toward the early detection of cancer by decoding the epigenetic and environmental fingerprints of cell-free DNA. Cancer Cell. 2019;36(4):350–368.
   PubMed Web of Science ®Google Scholar
• Chan KC, Jiang P, Chan CW, et al. Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing. Proc Natl Acad Sci USA. 2013;110(47):18761–18768.
   PubMed Web of Science ®Google Scholar
• Yeh P, Dickinson M, Ftouni S, et al. Molecular disease monitoring using circulating tumor DNA in myelodysplastic syndromes. Blood. 2017;129(12):1685–1690.
   PubMed Web of Science ®Google Scholar
• Cheng THT, Jiang P, Tam JCW, et al. Genomewide bisulfite sequencing reveals the origin and time-dependent fragmentation of urinary cfDNA. Clin Biochem. 2017;50(9):496–501.
   PubMed Web of Science ®Google Scholar
• Grunau C, Clark SJ, Rosenthal A. Bisulfite genomic sequencing: systematic investigation of critical experimental parameters. Nucleic Acids Res. 2001;29(13):E65–5.
   PubMedGoogle Scholar
• Zeng C, Stroup EK, Zhang Z, et al. Towards precision medicine: advances in 5-hydroxymethylcytosine cancer biomarker discovery in liquid biopsy. Cancer Commun. 2019;39(1):12.
   Google Scholar
• Song CX, Yin S, Ma L, et al. 5-Hydroxymethylcytosine signatures in cell-free DNA provide information about tumor types and stages. Cell Res. 2017;27(10):1231–1242.
   PubMed Web of Science ®Google Scholar
• Taiwo O, Wilson GA, Morris T, et al. Methylome analysis using MeDIP-seq with low DNA concentrations. Nat Protoc. 2012;7(4):617.
   PubMed Web of Science ®Google Scholar
• Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA. 2008;105(30):10513–10518.
   PubMed Web of Science ®Google Scholar
• Kopreski MS, Benko FA, Kwak LW, et al. Detection of tumor messenger RNA in the serum of patients with malignant melanoma. Clin Cancer Res. 1999;5(8):1961–1965.
   PubMed Web of Science ®Google Scholar
• Xu R, Rai A, Chen M, et al. Extracellular vesicles in cancer — implications for future improvements in cancer care. Nat Rev Clin Oncol. 2018;15(10):617–638.
   PubMed Web of Science ®Google Scholar
• Mayers JR, Wu C, Clish CB, et al. Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development. Nat Med. 2014;20(10):1193–1198.
   PubMed Web of Science ®Google Scholar
• Thierry AR, Tanos R, Otandault A, et al. Towards a screening test for cancer by circulating DNA analysis. JCO. 2019;37(15_suppl):e13146–e13146.
   Web of Science ®Google Scholar
• Meddeb R, Dache ZAA, Thezenas S, et al. Quantifying circulating cell-free DNA in humans. Sci Rep. 2019;9(1):5220.
   PubMedGoogle Scholar
• McConnell MJ, Moran JV, Abyzov A, et al. Intersection of diverse neuronal genomes and neuropsychiatric disease: the Brain Somatic Mosaicism Network. Science. 2017;356(6336):eaal1641.
   PubMed Web of Science ®Google Scholar
• Forsberg LA, Gisselsson D, Dumanski JP. Mosaicism in health and disease-clones picking up speed. Nat Rev Genet. 2017;18(2):128–142.
   PubMed Web of Science ®Google Scholar
• Aucamp J, Bronkhorst AJ, Badenhorst CP, et al. A historical and evolutionary perspective on the biological significance of circulating DNA and extracellular vesicles. Cell Mol Life Sci. 2016;73(23):4355–4381.
   PubMed Web of Science ®Google Scholar
• Shapiro JA. How life changes itself: The Read–Write (RW) genome. Phys Life Rev. 2013;10(3):287–323.
   PubMed Web of Science ®Google Scholar
• Stubbington MJT, Rozenblatt-Rosen O, Regev A, et al. Single-cell transcriptomics to explore the immune system in health and disease. Science. 2017;358(6359):58–63.
   PubMed Web of Science ®Google Scholar
• Shapiro E, Biezuner T, Linnarsson S. Single-cell sequencing-based technologies will revolutionize whole-organism science. Nat Rev Genet. 2013;14(9):618–630.
   PubMed Web of Science ®Google Scholar
• Lustberg MB, Stover DG, Chalmers JJ. Implementing liquid biopsies in clinical trials: state of Affairs, opportunities, and challenges. Cancer J. 2018;24(2):61–64.
   PubMed Web of Science ®Google Scholar